In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sysmex Corporation

https://www.sysmex.co.jp/en/

Latest From Sysmex Corporation

Start-Up Spotlight: Sight Diagnostics’ Imaging Technology Allows Accurate Diagnostics With Small Blood Samples

The US FDA recently cleared Sight’s Olo analyzer to run complete blood counts on samples as small as two drops. The company is currently marketing Olo to hospital labs in the US but hopes to eventually earn a CLIA waiver so Olo can be marketed to smaller physician practices and pharmacies and used for other common blood-based diagnostics.

Start-up Spotlight In Vitro Diagnostics

MTI Outlook 2020: Medtechs Enter The Decade Of Digital, Consumers and Wellness

For health-care providers and medtech manufacturers alike, the decade ahead will require a coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market-entry criterion, but companies will have to adapt to evolving health-care models. The stakes are high. Will manufacturers be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?

Commercial Innovation

Manufacturing Round-Up: JW Pharma Intensifies Expansion Plans In Vietnam

Japan's JW Pharma has acquired Euvipharm to expand in the Vietnamese pharmaceutical market, Schott and Velesco Pharma have set up new plants as part of their expansion plans, while other key collaborations have been struck.

Manufacturing Deals

German Diabetes Stakeholders Like The New Talk On Strategy And Reimbursement, But Where's The Action?

The up-to-10 million diabetics in Germany could benefit from a more optimal combination of digital tools and conventional case to maintain glucose control, say local IVD companies. But the industry is still waiting on the promised National Diabetes Strategy, while the government talks about more reimbursement support for innovation.

Germany In Vitro Diagnostics
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Medical Devices
    • Diagnostic Equipment & Supplies
  • Other Names / Subsidiaries
    • D’PULA Medical Solutions Corporation
    • Oxford Gene Technology
    • RIKEN GENESIS
    • Sysmex Egypt LLC
    • Sysmex-Inostics
    • Sysmex Middle East FZ-LLC
    • TOA Medical Electronics Co., Ltd.
UsernamePublicRestriction

Register